Arkolith/Insider Trading/ALLO/Form 4

Belldegrun Arie

DirectorAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed May 20, 2024
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2024Buy(P)1.7M$2.90$5.0M1.7M
May 16, 2024Grant(A)345K$2.90$1.0M540K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001737287-24-000042) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML